Cargando…
A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo
Despite major advances in the last 10 years, whether in terms of prevention or treatment, the 5 year survival rate remains relatively low for a large number of cancers. These therapeutic failures can be the consequence of several factors associated with the cellular modifications or with the host by...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072491/ https://www.ncbi.nlm.nih.gov/pubmed/32033130 http://dx.doi.org/10.3390/cells9020362 |
_version_ | 1783506418972753920 |
---|---|
author | Sioud, Fairouz Amor, Souheila Toumia, Imène ben Lahmar, Aida Aires, Virginie Chekir-Ghedira, Leila Delmas, Dominique |
author_facet | Sioud, Fairouz Amor, Souheila Toumia, Imène ben Lahmar, Aida Aires, Virginie Chekir-Ghedira, Leila Delmas, Dominique |
author_sort | Sioud, Fairouz |
collection | PubMed |
description | Despite major advances in the last 10 years, whether in terms of prevention or treatment, the 5 year survival rate remains relatively low for a large number of cancers. These therapeutic failures can be the consequence of several factors associated with the cellular modifications or with the host by itself, especially for some anticancer drugs such as cisplatin, which induces a nephrotoxicity. In the strategy of research for active molecules capable both of exerting a protective action against the deleterious effects of cisplatin and exerting a chemosensitizing action with regard to cancer cells, we tested the potential effects of Ephedra alata Decne extract (E.A.) rich in polyphenolic compounds towards a 4T1 breast cancer model in vitro and in vivo. We showed that E.A. extract inhibited cell viability of 4T1 breast cancer cells and induced apoptosis in a caspase-dependent manner, which involved intrinsic pathways. Very interestingly, we observed a synergic antiproliferative and pro-apoptotic action with cisplatin. These events were associated with a strong decrease of breast tumor growth in mice treated with an E.A./cisplatin combination and simultaneously with a decrease of hepato- and nephrotoxicities of cisplatin. |
format | Online Article Text |
id | pubmed-7072491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-70724912020-03-19 A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo Sioud, Fairouz Amor, Souheila Toumia, Imène ben Lahmar, Aida Aires, Virginie Chekir-Ghedira, Leila Delmas, Dominique Cells Article Despite major advances in the last 10 years, whether in terms of prevention or treatment, the 5 year survival rate remains relatively low for a large number of cancers. These therapeutic failures can be the consequence of several factors associated with the cellular modifications or with the host by itself, especially for some anticancer drugs such as cisplatin, which induces a nephrotoxicity. In the strategy of research for active molecules capable both of exerting a protective action against the deleterious effects of cisplatin and exerting a chemosensitizing action with regard to cancer cells, we tested the potential effects of Ephedra alata Decne extract (E.A.) rich in polyphenolic compounds towards a 4T1 breast cancer model in vitro and in vivo. We showed that E.A. extract inhibited cell viability of 4T1 breast cancer cells and induced apoptosis in a caspase-dependent manner, which involved intrinsic pathways. Very interestingly, we observed a synergic antiproliferative and pro-apoptotic action with cisplatin. These events were associated with a strong decrease of breast tumor growth in mice treated with an E.A./cisplatin combination and simultaneously with a decrease of hepato- and nephrotoxicities of cisplatin. MDPI 2020-02-04 /pmc/articles/PMC7072491/ /pubmed/32033130 http://dx.doi.org/10.3390/cells9020362 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sioud, Fairouz Amor, Souheila Toumia, Imène ben Lahmar, Aida Aires, Virginie Chekir-Ghedira, Leila Delmas, Dominique A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo |
title | A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo |
title_full | A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo |
title_fullStr | A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo |
title_full_unstemmed | A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo |
title_short | A New Highlight of Ephedra alata Decne Properties as Potential Adjuvant in Combination with Cisplatin to Induce Cell Death of 4T1 Breast Cancer Cells In Vitro and In Vivo |
title_sort | new highlight of ephedra alata decne properties as potential adjuvant in combination with cisplatin to induce cell death of 4t1 breast cancer cells in vitro and in vivo |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072491/ https://www.ncbi.nlm.nih.gov/pubmed/32033130 http://dx.doi.org/10.3390/cells9020362 |
work_keys_str_mv | AT sioudfairouz anewhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT amorsouheila anewhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT toumiaimeneben anewhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT lahmaraida anewhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT airesvirginie anewhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT chekirghediraleila anewhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT delmasdominique anewhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT sioudfairouz newhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT amorsouheila newhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT toumiaimeneben newhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT lahmaraida newhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT airesvirginie newhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT chekirghediraleila newhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo AT delmasdominique newhighlightofephedraalatadecnepropertiesaspotentialadjuvantincombinationwithcisplatintoinducecelldeathof4t1breastcancercellsinvitroandinvivo |